Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

593 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial.
Zeymer U, Suryapranata H, Monassier JP, Opolski G, Davies J, Rasmanis G, Linssen G, Tebbe U, Schröder R, Tiemann R, Machnig T, Neuhaus KL; ESCAMI Investigators. Zeymer U, et al. J Am Coll Cardiol. 2001 Nov 15;38(6):1644-50. doi: 10.1016/s0735-1097(01)01608-4. J Am Coll Cardiol. 2001. PMID: 11704395 Free article. Clinical Trial.
Early eptifibatide improves TIMI 3 patency before primary percutaneous coronary intervention for acute ST elevation myocardial infarction: results of the randomized integrilin in acute myocardial infarction (INTAMI) pilot trial.
Zeymer U, Zahn R, Schiele R, Jansen W, Girth E, Gitt A, Seidl K, Schröder R, Schneider S, Senges J. Zeymer U, et al. Eur Heart J. 2005 Oct;26(19):1971-7. doi: 10.1093/eurheartj/ehi293. Epub 2005 Apr 27. Eur Heart J. 2005. PMID: 15857851 Clinical Trial.
Incidence and predictors of target vessel revascularization and clinical event rates of the sirolimus-eluting coronary stent (results from the prospective multicenter German Cypher Stent Registry).
Zahn R, Hamm CW, Schneider S, Zeymer U, Nienaber CA, Richardt G, Kelm M, Levenson B, Bonzel T, Tebbe U, Sabin G, Senges J; German Cypher Stent Registry. Zahn R, et al. Among authors: zeymer u. Am J Cardiol. 2005 Jun 1;95(11):1302-8. doi: 10.1016/j.amjcard.2005.01.072. Am J Cardiol. 2005. PMID: 15904633
Predictors of death or myocardial infarction during follow-up after coronary stenting with the sirolimus-eluting stent. Results from the prospective multicenter German Cypher Stent Registry.
Zahn R, Hamm CW, Schneider S, Zeymer U, Richardt G, Kelm M, Levenson B, Bonzel T, Tebbe U, Sabin G, Nienaber CA, Senges J; German Cypher Stent Registry. Zahn R, et al. Among authors: zeymer u. Am Heart J. 2006 Dec;152(6):1146-52. doi: 10.1016/j.ahj.2006.07.011. Am Heart J. 2006. PMID: 17161068
Prognostic impact of acute beta-blocker therapy on top of aspirin and angiotensin-converting enzyme inhibitor therapy in consecutive patients with ST-elevation acute myocardial infarction.
Wienbergen H, Zeymer U, Gitt AK, Juenger C, Schiele R, Heer T, Towae F, Senges J; MITRA PLUS Study Group. Wienbergen H, et al. Among authors: zeymer u. Am J Cardiol. 2007 May 1;99(9):1208-11. doi: 10.1016/j.amjcard.2006.12.036. Epub 2007 Mar 16. Am J Cardiol. 2007. PMID: 17478143
593 results